Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial.

OBJECTIVE: Vitamin E, the most potent naturally occurring lipid soluble antioxidant has been suggested to possess both anti-inflammatory and analgesic activity in humans. This double blind and randomised study used a broad spectrum of clinical and laboratory parameters to investigate whether there was any additional anti-inflammatory or analgesic effects, or both, of orally administered alpha-tocopherol in rheumatoid arthritis patients who were already receiving anti-rheumatic drugs. METHODS: Forty two patients were enrolled and treated with alpha-tocopherol (n = 20) at a dose of 600 mg twice a day (2 x 2 capsules) or with placebo (n = 22) for 12 weeks. The following parameters were measured: (1) Three clinical indices of inflammation--the Ritchie articular index, the duration of morning stiffness, and the number of swollen joints; (2) three measures of pain--pain in the morning, pain in the evening, and pain after chosen activity; (3) haematological and biochemical measures of inflammatory activity; (4) assays for the oxidative modification of proteins and lipids. RESULTS: All laboratory measures of inflammatory activity and oxidative modification were unchanged. Furthermore, the clinical indices of inflammation were not influenced by the treatment. However, the pain parameters were significantly decreased after vitamin E treatment when compared with placebo. CONCLUSION: The results provide preliminary evidence that vitamin E may exert a small but significant analgesic activity independent of a peripheral anti-inflammatory effect, but which complements standard anti-inflammatory treatment.

Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid.

OBJECTIVE: To demonstrate directly that highly reactive hydroxyl radicals (OH.) can be generated in patients with rheumatoid arthritis and contribute to joint damage, and to examine the ability of blood to cause OH. generation. METHODS: The sensitive and specific technique of hydroxylation of aromatic compounds (salicylate and phenylalanine) was used to measure OH.. Synovial fluid and blood from patients with active rheumatoid arthritis were aspirated and immediately added to tubes containing salicylate and phenylalanine as detectors of OH., or to tubes containing saline as a control. Levels of specific products of attack of OH. upon salicylate (2,3- and 2,5-dihydroxybenzoates) and phenylalanine (ortho- and meta-tyrosines) were measured by high performance liquid chromatography. RESULTS: Synovial fluid samples aspirated into saline never contained ortho- or meta-tyrosines or 2,3-dihydroxybenzoate. Of 53 patients examined, synovial fluid and blood from 36 caused formation of ortho- and meta-tyrosines when aspirated into solutions containing phenylalanine. Repeated sampling from three "positive" patients showed consistent evidence of these hydroxylation products. Similarly, of 22 patients examined, synovial fluid and blood from 18 caused formation of 2,3- and 2,5-dihydroxybenzoates when aspirated into salicylate solutions. Further evidence for the role of OH. was provided by inhibition of the hydroxylation by the specific OH. scavengers mannitol and sodium formate. CONCLUSIONS: Aspirated knee joint fluids and blood from rheumatoid arthritis patients can generate OH., consistent with current views on the importance of this radical as a cytotoxic agent in rheumatoid disease. The ability of body fluids to cause OH. formation is not correlated with simple laboratory indices of disease activity, but is reproducible on sequential sampling from the same patients. The mechanism and significance of the phenomenon in rheumatoid arthritis pathology remain to be established.

An imaginative approach to synovitis--the role of hypoxic reperfusion damage in arthritis.

The rheumatoid joint is hypoxic. The loss of the physiologic defense mechanism, reflex muscle inhibition, allows the generation of high intraarticular pressures, particularly during exercise. Hypoxia alters the biochemistry of the synovium and encourages the production of reactive oxygen species (ROS) on reperfusion of blood. In excess, ROS damage tissues, and the products of oxidative damage are detectable in rheumatoid synovial fluid. In addition to damaging proteins, carbohydrates and lipids, cellular and structural damage also occurs.

The use of balloon catheters in the treatment of epistaxis.

Inflatable balloon catheters are widely used in the treatment of severe epistaxis and are designed to be filled either with air or liquid. A postal survey revealed that 87 per cent of respondents used an inflatant which was deemed inappropriate by the manufacturer. When balloons designed for water or saline were filled with air, they deflated rapidly, in some cases being virtually empty after 24 hours. Better and more accessible instruction leaflets are required if the balloons are to be used as intended. Foley catheters are frequently used as nasopharyngeal packs, in conjunction with anterior nasal packs. Paraffin in the commonly used anterior packs damages the rubber of the catheter, resulting in the balloon bursting. This should be recognized by clinicians as a possible cause of rebleeding.

Resources for the visually impaired.

There is a vast network of agencies across the country that provide services or information to people with vision problems. Eyecare providers are a key way to provide information to this population. Resources outlining financial benefits for the visually impaired on the federal and state level are available. A small investment of time to write or call for resources is the first step in making referrals that may make a significant difference for patients.

Vision parameters in krypton and laser photocoagulation of subfoveal neovascular membranes.

A prospective study of 78 patients, treated with krypton red laser (KRL) photocoagulation, who had senile macular degeneration (SMD) and subretinal neovascular membranes (SRNVM) located within 200u of the center of the foveal avascular zone (FAZ), was undertaken to determine if complete eradication of the SRNVM would minimize the resultant foveal scar size and retain the maximal useful functional vision as compared to untreated fellow eyes with a disciform scar. The typical patient profile with SMD and subfoveal SRNVM included: average age, 73.6 years; caucasian, 99%; females, 62%; lightly pigmented iris, 70%; hyperopic refractive error, 93%; and evidence of bilateral involvement with either predisciform or disciform lesions, 73%. In comparing eyes treated with KRL having 100% FAZ involvement with fellow untreated eyes having disciform scars, the latter had poorer average visual acuity (44% vs 100% less than or equal to 20/200), scars which were an average of five times larger (8.4 vs 38.6 sq mm) and scotomas which were an average of six times larger (15.7 vs 90 sq cm) as determined by new microcomputer technology. In all bilaterally affected cases, eyes with smaller scars and scotomas required less magnification from a low vision aid to read continuous standardized 1M print. Sixteen of 17 patients (94%) preferred the low vision aid for their treated eye. These preliminary results suggest that treatment of SRNVM within the FAZ using KRL may be successful in arresting the progressive macular hemorrhagic-exudative damage typical of untreated cases which culminate in loss of central visual function. Successful treatment, by preserving areas of paracentral fixation, can enhance the chances of visual rehabilitation using conventional low vision aids.